Table 3.
Univariate analysis for predictors of recurrence
| Total | 5-yr survival (%) | Median survival (mo) | Univariate analysis P | |
| Overall | 158 | 83.3 | - | - |
| Age (≥ 60 yr) | - | - | - | 0.319 |
| Male gender | - | - | - | 0.410 |
| BMI (≥ 28) | - | - | - | 0.166 |
| Pre-op AFP (≥ 100 mg/dL) | 0.001 | |||
| Yes | 19 | 59.4 | 84.5 | |
| No | 129 | 85 | - | |
| Cirrhosis | - | - | - | 0.163 |
| Alcohol related | - | - | - | 0.207 |
| Hepatitis B infection | - | - | - | 0.911 |
| Hepatitis C infection | - | - | - | 0.568 |
| Others | - | - | - | 0.794 |
| Blood type | - | - | - | 0.912 |
| Rhesus | - | - | - | 0.494 |
| MELD (≥ 15) | - | - | - | 0.694 |
| Radiofrequency | - | - | - | 0.758 |
| Chemoembolization | - | - | - | 0.133 |
| Tumor alcoholization | - | - | - | 0.373 |
| Graft/body % (≥ 2) | - | - | - | 0.605 |
| Number of lesions (> 3) | - | - | - | 0.496 |
| Largest lesion mm (≥ 30) | - | - | - | 0.429 |
| Edmond-Steiner degree | 0.0162 | |||
| III-IV | 88 | 73 | 84.5 | |
| 0-II | 59 | 94.3 | - | |
| Vascular invasion | 0.071 | |||
| Yes | 26 | 74.8 | 84.5 | |
| No | 132 | 86.3 | - | |
| Microsatellite lesions | 0.007 | |||
| Yes | 26 | - | - | |
| No | 132 | 86.5 | - | |
| Cholangiocarcinoma | - | - | - | 0.375 |
| IBS | 0.953 | |||
| Yes | 122 | 85 | 84.5 | |
| No | 36 | 78.8 | - |
BMI: Body mass index; AFP: Alpha-feto protein; IBS: Intraoperative blood salvage; MELD: Model of End-Stage Liver Disease.